Picture

ABOUT

The Asian Society of Neuro-Oncology (ASNO) is a multi-disciplinary organization dedicated to promoting advances in Neuro-oncology through research and education. Every winter, over 400 neurosurgeons and medical professionals from 10 member-countries gather, and together with invited guests from around the globe, we share our knowledge and experience, engage in spirited discussion to refine our ideas, and enjoy the hospitality of friends. This year, ASNO 2019, the 16th annual meeting of the Asian Society for Neuro-oncology, will be held from September 27 to 29, 2019 in Taipei, Taiwan. We eagerly await esteemed members’ productive participation.

 

Dear colleagues and guests:

The Asian Society of Neuro-Oncology (ASNO) is a multi-disciplinary organization dedicated to promoting advances in Neuro-oncology through research and education. Every winter, over 400 neurosurgeons and medical professionals from 10 member-countries gather, and together with invited guests from around the globe, we share our knowledge and experience, engage in spirited discussion to refine our ideas, and enjoy the hospitality of friends. This year, ASNO 2019, the 16th annual meeting of the Asian Society for Neuro-oncology, will be held from September 27 to 29, 2019 in Taipei, Taiwan. We eagerly await esteemed members’ productive participation.

 

致各位神經腫瘤的前輩及同儕們：

亞洲神經腫瘤學會（ASNO）自成立即致力於透過研究和教育促進神經腫瘤醫學的進步。每年冬天，我們來自10個成員國的400多名神經外科醫生和醫療專業人士聚集在一起，與來自世界各地的特邀嘉賓一起分享我們的知識和經驗，經由激烈的討論來完善我們對腫瘤生理及治療的認知，並借此機會享受朋友的熱情款待。今年，亞洲神經腫瘤學會第16屆年會將於2019年9月27日至29日在台灣的台北市舉行。我們熱切期盼各位會員及嘉賓的蒞臨指導。

  • ASNO Honorary President
    Prof. Ming-Chien Kao

  • ASNO Honorary President
    Prof. Wen-Ta Chiu

  • ASNO President
    Prof. Kuo-Chen Wei

Important Dates

  • Abstract Submission Closes
    June 14, 2019
  • Late-Breaking Abstracts Closes
    July 31, 2019
  • Notification of Abstract Review Results
    July 31, 2019
  • Early-bird Registration Closes
    July 31, 2019
  • Last Day for Cancellation of Registration with 75% Refund
    August 25, 2019
  • On-line Registration Closes
    September 8, 2019

Sign in / Sign up

Speaker

  • Keynote Speaker

    Speakers order is based on alphabet order A-Z

  •  

    Invited Speaker


    • Abel Po-Hao Huang
      National Taiwan University Hospital, Taiwan

    • Akitake Mukasa
      Kumamoto University, Japan

    • Cheng Hong Toh
      Linkou Chang Gung Memorial Hospital, Taiwan

    • Chen-Kan Tseng
      Chang Gung Memorial Hospital, Taiwan

    • Cheng-Chia Lee
      Taipei Veterans General Hospital, Taiwan

    • Chih-Ju Chang
      Cathay General Hospital, Taiwan

    • Diego Shih-Chieh Lin
      Taipei Veterans General Hospital, Taiwan

    • Der Yang Cho
      China Medical University, Taiwan

    • Eng-Siew Koh
      University of New South Wales, Australia

    • Fon-Yih Tsuang
      National Taiwan University Hospital, Taiwan

    • Fumio Yamaguchi
      Nippon Medical School, Japan

    • Gordon Li
      Stanford University Medical Center, USA

    • Guihuai Wang
      Beijing Tsinghua Chang Gung Hospital, China

    • Hideki Murakami
      Nagoya City University, Japan

    • Ho-Keung Ng
      The Chinese University of Hong Kong, HK

    • Jay-Jiguang Zhu
      UT Houston, USA

    • Jinquan Cai
      Harbin Medical University, China

    • Julette Batara
      University of the Philippines, Philippines

    • Koichi Ichimura
      National Cancer Center Research Institute, Japan

    • Kaoru Kurisu
      Hiroshima University, Japan

    • L. Eric Huang
      The University of Utah, USA

    • Motoo Nagane
      Kyorin University, Japan

    • Mitsutoshi Nakada
      Kanazawa University, Japan

    • Rakesh Rattan Jalali
      Apollo Proton Cancer Centre, India

    • Rusdy Ghazali Malueka
      Dr Sardjito General Hospital, Indonesia

    • Ryuta Saito
      Hokkaido University, Japan

    • Sith Sathornsumetee
      Mahidol University, Thailand

    • Shinya Tanaka
      Tohoku University Hospital, Japan

    • Shozo Yamada
      Moriyama Neurological Center Hospital, Japan

    • Se-Hyuk Kim
      Ajou University, Korea

    • Takashi Komori
      Tokyo Metropolitan Neurological Hospital, Japan

    • Tai Tong Wong
      Taipei Medical University Hospital, Taiwan

    • Tao Jiang
      Beijing Tiantan Hospital, China

    • Vincent Nga
      National University Cancer Institute, Singapore

    • Wai Sang Poon
      The Chinese University of Hong Kong, HK

    • Wan-Yuo Guo
      Taipei Veterans General Hospital, Taiwan

    • William Ho Cheung Li
      University of Hong Kong, HK

    • Xiangen Shi
      Beijing Sanbo Brain Hospital Capital Medical  University, China

    • Yong-Kil Hong
      The Catholic University of Korea, Korea

    • Yazmin Odia
      Baptist Health South Florida, USA

    • Zhongping Chen
      Sun Yat-sen University Cancer Center, China

 

Program

To download the Program at-a-glance　　 　 　 　 　

█：International　█：201
  • Day 1 - Sep. 26 Thursday
    13:00-17:00
    Registration
  • Day 2 - Sep. 27 Friday
    08:00-18:00
    Registration
    08:20-08:30
    Opening Remark: Challenge of glioma treatment
    08:30-10:30
    Keynote Speech (I)
    8:30-9:00
    Proton therapy: another option in radiation therapy for CNS tumors
    Chen-kan Tseng
    9:00-9:30
    The times they are a-changin. How molecular pathology changed practice for brain tumor diagnosis?
    Ho-Keung Ng
    9:30-10:00
    Neurotransmission and glioblastoma: therapeutic potential of dopamine inhibition
    Clark C. Chen
    10:00-10:30
    Personalized immunotherapy
    Michael Lim
    10:30-10:50
    Coffee Break
    10:50-12:20
    Keynote Speech (II)
    10:50-11:20
    Imaging the Glioblastoma Margin
    Stephen J. Price
    11:20-11:50
    Update on non-surgical treatment for low grade gliomas
    Michael Weller
    11:50-12:20
    Surgery for low grade gliomas: the state of the art
    Mitchel S. Berger
    12:20-13:20
    Lunchtime Seminar (I)
     
    Cerebral cavernoma malformation with drug resistant epilepsy
    Cheng-chia Lee
    ASNO Business Meeting
    13:20-15:20
    Keynote Speech (III)
    13:20-13:50
    Clinical trials updates for lower grade glioma.
    Patrick Y. Wen
    13:50-14:20
    Enabling Access to Radiosurgery for 2 Million Patients per Year
    John R. Adler
    14:20-14:40
    Molecular Profiling of Gliomas: Implications for Prognosis and Treatment
    Yazmin Odia
    14:40-15:00
    Temozolomide Resistance in Glioblastoma
    Wai Sang Poon
    15:00- 15:20
    Impact of modern high precision photon and proton beam therapy to improve survivorship in brain tumour patients
    Rakesh Rattan Jalali
    13:40-17:10
    Joint Neuropathology Session with Japan Society of Brain Tumor Pathology (JSBTP)
    13:40-13:50
    Opening & Introduction
    Kaoru Kurisu
    Kuo-Chen Wei
    13:50-14:20
    cIMPACT-NOW in an Asian context, beyond WHO2016 Classification of Tumors of CNS
    Takashi Komori
    14:20-14:50
    Morphological and genetic analysis of meningioma
    Shinya Tanaka
    14:50-15:20
    Pathology of pineal region tumor – experience of Taipei Veterans General Hospital
    Diego Shih-Chieh Lin
    15:40-16:10
    Therapeutic strategies based on temporal and spatial heterogeneity of gliomas
    Akitake Mukasa
    16:10-16:40
    The world of Eph/ephrintyrosine kinase family in glioma
    Mitsutoshi Nakada
    16:40-17:10
    Advanced and additional image diagnoses for brain tumors and their environments
    Kaoru Kurisu
    15:20-15:35
    Coffee Break
    15:35-17:35
    Spinal tumor session
    15:35-16:05
    Evaluation and Management of Metastatic Spine Tumors – Current Update
    Fon-Yih Tsuang
    16:05-16:35
    Surgical Techniques of Total En Bloc Spondylectomy
    Hideki Murakami
    16:35-17:05
    The Treatment of Strategy for Brainstem and Spinal Cord Hemangioblastoma
    Chih-Ju Chang
    17:05-17:35
    Intramedullary spinal tumor treatment
    Guihuai Wang
    18:30-21:00
    Welcome Reception
  • Day 3 - Sep. 28 Saturday
    07:30-18:00
    Registration
    08:10-08:20
    Opening remark: Role of ASNO in neuro-oncology
    Kuo-Chen Wei
    08:20-08:40
    Collaboration for healthcare improvement
    Honorary Presidents
    08:40-10:25
    Plenary Speech (I)
    08:40-09:15
    The present and future of neurooncology-from neurosurgical aspect?
    Mitchel S. Berger
    09:15-09:50
    Molecular targeted therapy of glioblastoma
    Michael Weller
    09:50-10:25
    Progress of glioma treatment in China
    Tao Jiang
    10:25-10:40
    Coffee Break
    10:40-12:25
    Plenary Speech (II)
    10:40-11:15
    The present and future in the treatment of metastatic brain tumors
    Patrick Y. Wen
    11:15-11:50
    Current state of immunotherapy
    Michael Lim
    11:50-12:25
    Recent Progress in Total En Bloc Spondylectomy
    Hideki Murakami
    12:25-13:25
    Lunchtime Seminar (II): Chiu Ho Medical System Company
    　　　　　　
    How we should interpret fluorescence signals for neurosurgery
    Kyousuke Kamada
    13:30-15:25
    Expert Session (I)
    13:30-13:50
    Cell Therapy with Dendritic Cells and Chimeric Antigen Receptor T-Lymphocyte and NK Cells (Car-T, Car-NK) for Glioblastoma Multiforme
    Der-Yang Cho
    13:50-14:05
    Intraoperative brain mapping by a novel and simple method for the maximal safe resection of tumors
    Fumio Yamaguchi
    14:05-14:20
    Malignant Brain Tumors in the Elderly- Identifying predictors of surgical outcomes
    Vincent Nga
    14:20-14:25
    Break
    14:25-14:40
    Prognostic factors in stereotactic radiosurgery for brain metastases
    Se-Hyuk Kim
    14:40-14:55
    Recent Advances in Targeted Therapy For Glioma
    Jinquan Cai
    14:55-15:10
    Strategies for MGMT promote unmethylated gliomas
    Zhongping Chen
    15:10-15:25
    Incorporation of MRI and PET imaging in adaptive radiotherapy (ART) approaches for glioma management
    Eng-Siew Koh
    15:25-15:40
    Coffee Break
    15:40-18:00
    Expert Session (II) & (III)
    15:40-15:55
    Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
    Gordon Li
    15:55-16:10
    Is viroimmunotherapy a new hope for malignant gliomas?
    Yong-Kil Hong
    16:10-16:25
    Standard of care and novel therapeutic insights for primary central nervous system lymphoma
    Motto Nagane
    16:25-16:30
    Break
    16:30-16:45
    Management and Outcomes of Primary CNS Lymphoma in the Philippines
    Julette Batara
    16:45-17:00
    Treatment of Lower-grade Gliomas: More Evidence but Still Controversial
    Sith Sathornsumetee
    17:00-17:15
    Convection-enhanced Delivery of Nimustine Hydrochloride (ACNU) for Patients With Malignant Glioma
    Ryuta Saito
    17:15-17:20
    Break
    17:20-17:35
    Molecular Profiling of Glioma in Indonesia and Its Association with Clinicopathologic Factors
    Rusdy Ghazali Malueka
    17:35-17:50
    The IDH1R132H inhibitor AGI-5198 promotes glioma growth by boosting redox homeostasis
    L. Eric Huang
    17:50-18:05
    Transcranial Surgery with Drilling Tuberculum Sellae/anterior Clinoidotomy for the Resection of Intrasella and Cavernous Sinus Craniopharyngioma in 60 patients
    Xiangen Shi
    13:30-18:00
    Expert Session (Rapid Report-I) Nursing Session
    19:00-21:00
    Gala Dinner
  • Day 4 - Sep. 29 Sunday
    08:00-12:00
    Registration
    08:10-10:10
    Plenary Speech (III)
    8:10-8:40
    Advances in the diagnosis and treatment of adult gliomas
    Koichi Ichimura
    8:40-9:10
    Endoscopic transnasal approach for the treatment of various types of craniopharyngiomas
    Shozo Yamada
    9:10-9:40
    Management of medulloblastoma in children in the molecular era
    Tai-Tong Wong
    9:40-10:10
    The effectiveness of musical training in reducing depressive symptoms and promoting quality of life among pediatric brain tumor survivors
    William Ho Cheung Li
    10:10-10:25
    Coffee Break
    10:25-11:15
    Plenary Speech (III)
    10:25-10:45
    Clinical Application of Imaging AI in Neuro-oncology: Real Word Experience Sharing
    Wan Yuo Guo
    10:45-11:00
    Early-stage Glioblastomas: MR Classification and Growth Stages
    Cheng Hong Toh
    11:00-11:15
    Contemporary management of brain metastasis
    Abel Po-Hao Huang
    08:10-10:18
    Expert Session (Rapid Report II)
    11:15-12:00
    Award Presentaion
    11:15-11:30
    JNO Award Presentation
    Tumor Treating Fields plus temozolomide for newly diagnosed glioblastoma – a sub-group analysis of Korean patients in the EF-14 phase 3 trial
    Chae-Yong Kim
    11:30-11:45
    DEN-MEI BRAIN TUMOR EDUCATION FOUNDATION Award Presentation
    LGR5 and downstream intracellular signaling proteins play critical roles in the cell proliferation of neuroblastoma and brain tumors such as meningioma and pituitary adenoma
    Myung-Hoon Han
    11:45-12:00
    Cerebrovascular Disease Prevention and Treatment Foundation Award Presentation
    Myoinositol/ total choline ratio in IDH wild-type gliomas obtained by magnetic resonance spectroscopy can be used as a preoperative prognostic factor.
    Masanobu Kumon
    12:10-13:30
    Lunchtime Seminar (III)
    12:10-13:10
    Tumor treating fields: a novel and effective therapy for glioblastoma
    Jay Zhu
    13:10-13:30
    Clinical adoption of tumor treating fields in Hong Kong
    Lai-Fung Li
    13:30-13:35
    Close Remark / Kuo-Chen Wei
    13:35-13:45
    Introduce 2020 / Henry Riyanto Sofyan
    14:00-16:00
    The 9th Taiwan Society for Neuro-oncology Annual Meeting

Location

HNBK International Convention Center

With a variety of venues, first-class hardware facilities and professional conference services, we offer a wide range of venue services from large international conference, concerts, seminars, product launch party and festive banquets.

Address:No.123, Songren Rd., Xinyi Dist., Taipei City 110, Taiwan (R.O.C.)


Transportation

 

My ASNO